Your browser is too old
We can't provide a great video experience on old browserUpdate now
Chronic meningitis is the predominant concept which has been deliberated in this sqadia.com medical video lecture. This V learning lecture provides a detailed interpretation of the intracranial and spinal meningitis. In addition to this, infectious meningitis together with the bacterial and viral meningitis has been delineated. Furthermore, non-infectious meningitis along with the treatment and approach to the enigmatic patient has been expansively elucidated.
Intracranial and Spinal Meningitis
In the beginning of this section, an overview of the chronic meningitis has been put forth. Following this, categories along with the signs and symptoms have been presented. Additionally, clinical pathophysiology and intracranial meningitis has been discussed. Conclusively, spinal meningitis alongside the systemic manifestations have been reported.
Section two emphasizes on the infectious meningitis. Firstly, fungal causes have been reported. Subsequently, protozoal causes have been highlighted in-detail. In the end, helminthic causes in conjunction with the rare helminthic causes have been explained.
Bacterial and Viral Meningitis
At the onset of this section, common bacterial causes have been described in tabular form. Moving further, viral causes, mumps alongside the lymphocytic choriomeningitis has been brought under consideration. Moreover, echovirus, HIV and herpes simplex (HSV) has been expounded.
Initially, malignancy, risk factors together with the chemical compounds have been deliberated. In addition to this, CNS sarcoidosis, systemic manifestations alongside the Vogt-Koyanagi-Harada syndrome has been conversed about. Afterwards, isolated granulomatous angiitis of nervous system, systemic lupus erythematosus and Behcet’s syndrome has been highlighted. Also, Mollaret’s meningitis, drug hypersensitivity and granulomatosis with polyangiitis (Wegener’s) has been described.
Section five focuses on the treatment. Firstly, approach to enigmatic case and empirical treatment has been delineated. Furthermore, antimycobacterial agents have been brought under discussion. Then this section has been summed up by a debate on the immunocompromised patients.